Application de la télésurveillance médicale à l’oncologie : référentiel AFSOS pour une prise en charge en 2025

Telemonitoring in oncology has developed in recent years, significantly improving the quality of life and overall survival of patients being treated for any type of cancer (Basch and al., 2016). In France, its growth in hospital has been strengthened by the two decrees of December 2022 (n°2022-1767, n°2022-1769) establishing a common law model and reimbursement by the Social Security from July 2023. We thought it was necessary to create French guidelines for all healthcare professionals wishing to carry out telemonitoring activity within their oncology center. We therefore propose clarifying the indications for telemonitoring, exploring the regulations surrounding digital medical device, how it works, and the role of the various healthcare professionals involved in the practice. We also address ethical considerations before outlining the approach to be followed by professionals to follow for optimal implementation. This article focuses particularly on this last part to facilitate the application of the recommendation by healthcare professionals wishing to integrate a telemonitoring activity.